Abstract
Antimicrobial resistance is a major global health challenge. As few new efficacious antibiotics will become available in the near future, peptide antibiotics continue to be major therapeutic options for treating infections caused by multidrug-resistant pathogens. Rational use of antibiotics requires optimisation of the pharmacokinetics and pharmacodynamics for the treatment of different types of infections. Toxicodynamics must also be considered to improve the safety of antibiotic use and, where appropriate, to guide therapeutic drug monitoring. This review focuses on the pharmacokinetics/pharmacodynamics/toxicodynamics of peptide antibiotics against multidrug-resistant Gram-negative and Gram-positive pathogens. Optimising antibiotic exposure at the infection site is essential for improving their efficacy and minimising emergence of resistance.
Original language | English |
---|---|
Article number | 114171 |
Number of pages | 27 |
Journal | Advanced Drug Delivery Reviews |
Volume | 183 |
DOIs | |
Publication status | Published - Apr 2022 |
Keywords
- Antibiotics
- Antimicrobial peptide
- Antimicrobial resistance
- Pharmacodynamics
- Pharmacokinetics
- Safety
- Therapeutic drug monitoring